Table 1.
Sample characteristics.
| Characteristics | Overall (n = 629) |
|---|---|
| Age, years, Median (IQR) | 44 (34–53) |
| Year of genotyping, n (%) | |
| <2020 | 28 (4.4) |
| 2020–2021 | 104 (16.5) |
| 2022–2023 | 497 (79.1) |
| Plasma HIV-1 RNA, log (copies/mL), Median (IQR) | 4.9 (4.2–5.6) |
| ≤1000 copies/mL, n (%) | 41 (6.5) |
| 1001–10,000 copies/mL, n (%) | 90 (14.3) |
| 10,001–100,000 copies/mL, n (%) | 207 (32.9) |
| 100,001–1,000,000 copies/mL, n (%) | 212 (33.7) |
| >1,000,000 copies/mL, n (%) | 79 (12.6) |
| HIV-1Subtype, n (%) 1 | |
| B | 370 (58.8) |
| CRF02_AG | 88 (14.0) |
| F | 37 (5.9) |
| C | 36 (5.7) |
| A | 38 (6.0) |
| G | 19 (3.8) |
| Others 2 | 41 (6.5) |
| Treatment status, n (%) | |
| Naive | 313 (49.8) |
| Experienced | 152 (24.2) |
| Unknown | 164 (26.1) |
| Platform used for NGS | |
| iSeq100 | 485 (77.1) |
| MiSeq | 144 (22.9) |
1 Subtype assessed through HIVdb algorithm 9.5.1. 2 Other subtypes: B + F (N = 10), CRF01_AE (N = 9), B + G (N = 5), CRF18_cpx (N = 4), CRF06_cpx (N = 2), CRF09_cpx (N = 2), CRF25_cpx (N = 2), D (N = 2), A + G (N = 1), B + C (N = 1), B + CRF01_AE (N = 1), CRF12_BF (N = 1), CRF29_BF (N = 1).